none

CSIRO IS ON A HEALTH KICK

05-09-2017
by 
in 
CSIRO M2 programme

Breakthroughs and remarkable discoveries are expected from the new "M2" programme between CSIRO and Monash University, as the two scientific behemoths collaborate to "bring the best minds and technology together to turn great ideas into a reality for Australia’s flourishing medtech industry". 

As innovation continues to be the watchword for Australian industry, efforts by the government to reinvest in science and technology are continuing apace. 

“From life-changing cochlear implants, to life-saving vaccines, world-first 3D printed bone and tissue replacements, Australia has an incredible track record when it comes to medical technologies and pharmaceuticals,” Senator Arthur Sinodinos said.

“M2 will help to accelerate development of technology like this, not only vital for the improvement of the lives of Australians facing medial challenges, but also leading to job and economic growth for Australia.”

Supported by the Science and Industry Endowment fund, M2 aims to bridge the gap between Australia's many small- and medium-sized medical technology enterprises, and the often-exorbitant cost of prototyping and developing new products. 

M2 will be providing a research ecosystem for these companies, helping to transition new discoveries from the bench to prototyping, pre-clinical testing, industry evaluation and commercialisation.

“M2 leverages some of Australia’s best medtech expertise, experience and equipment,” CSIRO Director of Manufacturing Dr Keith McLean said.

“When a company comes to us we can use CSIRO and MHTP facilities to develop and analyse production scale prototypes, whilst the Monash Biomedical Imaging facility can provide advanced pre-clinical and clinical testing and imaging.”

With global populations ageing and emerging markets seeking better health care, there’s huge growth underway in the MTP sector. It’s expected to be worth almost $3 trillion by 2025, while $18 billion and 28,000 new jobs could be added to the Australian economy over the next eight years.

“Monash is determined to help build a new, globally competitive biomedical industry with our partners,” Monash University Provost and Senior Vice-President Professor Marc Parlange said.

“This initiative will deliver real health benefits to all Australians. Our healthcare spending is expected to almost double to 16 per cent of GDP by 2040. Cheaper and more effective medical solutions are better for our health and Australia’s financial future.”

Related news & editorials

  1. 19.11.2018
    19.11.2018
    by      In
    Leading engineering technology and systems innovation consultancy Frazer-Nash has tripled the size of its Adelaide headquarters, with SA premier Steven Marshall officiating at the recent opening ceremony.
    The company’s Australian Director, Jonathan Armstrong said: “We’ve created 40 high value jobs... Read More
  2. 19.11.2018
    19.11.2018
    by      In
    Following the success of this year’s Electronex at Rosehill Gardens in Sydney, the show organiser has announced that the 2019 Expo will be held in the new extension of the Melbourne Convention & Exhibition Centre on the 11th and 12th September next year.
    The Sydney event was judged an... Read More
  3. 15.11.2018
    15.11.2018
    by      In
    It’s less than a year since Lapp Australia started trading, but the company has swiftly established itself in the local market, with significant penetration in sectors such as food and beverage, manufacturing, solar, sound and stage production, electrical contracting, machine building and... Read More
  4. 12.11.2018
    12.11.2018
    by      In
    Energy Vault has developed a novel solution to storage for renewable energy plants that involves neither batteries nor water.
    The Energy Vault system is based on the fundamental physics of potential and kinetic energy, and uses a proprietary, cloud-based software platform to operate a newly... Read More